MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from warrant
exchanges, net of offering...
$2,984K
Proceeds from pre-paid
advances, net of discounts
$2,850K
Proceeds from issuance of
common stock, net of...
$1,819K
Proceeds from issuance of
common stock in...
$1,595K
Proceeds from issuance of
warrants, net of offering...
$481K
Proceeds from warrant
exercises with common...
$22K
Proceeds from issuance of
common stock in...
$4K
Net cash provided by
financing activities
$9,755K
Net decrease in cash
and cash...
-$9,650K
Canceled cashflow
$9,755K
Impairment loss on
intangible assets
$28,700K
Accounts payable
$3,065K
Stock-based compensation
expense
$2,224K
Commitment fee related to
pre-paid advance...
$300K
Original issue discount
related to pre-paid...
$150K
Depreciation and
amortization expense
$1K
Net cash used in
operating activities
-$19,361K
Canceled cashflow
$34,440K
Effect of exchange rate
changes on cash and cash...
-$44K
Net loss
-$49,871K
Accrued expenses and
other current...
-$2,622K
Deferred tax liabilities
-$712K
Prepaid expenses and
other current assets
$319K
Other long-term
liabilities
-$277K
Back
Back
Cash Flow
source: myfinsight.com
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)